Kadmon Corporation to Present at the 8th Annual JMP Securities Healthcare Conference
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 07/02/13 -- Kadmon Corporation, LLC, today announced that Samuel D. Waksal, Ph.D., Chairman and Chief Executive Officer of Kadmon, will present at the 8th Annual JMP Securities Healthcare Conference on Tuesday, July 9 at 2:00 p.m. Eastern Time in New York City. Dr. Waksal will provide an overview of Kadmon and its commercial and clinical programs.
A live audio webcast of the presentation will be accessible through Kadmon's website at . The webcast will be archived for 90 days.
Kadmon Corporation, LLC, is a global company built on a 21st-century paradigm for the translation of innovative science into treatment. The company currently offers products and services for the treatment and management of hepatitis C, and is pioneering novel medicines in areas of serious disease, including oncology, infectious diseases, immunology and neurodegenerative diseases. Emphasizing emerging concepts in molecular biology and genomics, Kadmon is developing treatments and treatment combinations that target the metabolomics and signaling pathways associated with disease, with the goal addressing some of today's most pressing areas of unmet medical need. For more information, visit .
David Pitts
Argot Partners
212.600.1902
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.07.2013 - 12:00 Uhr
Sprache: Deutsch
News-ID 274998
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 212 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Kadmon Corporation to Present at the 8th Annual JMP Securities Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Kadmon Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
